CIK 0001735438 · Non-accelerated filer<br>Smaller reporting company
MeiraGTx Holdings plc
Sign in to watch- Ticker
- MGTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981448305
- Phone
- 646-860-7985
- Business address
- 655 THIRD AVENUE, SUITE 1115, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,710,812
- in 3 filings, $1.7M under 10b5-1 plans
Net −$1,710,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 30 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-09 | Forbes Alexandria President and CEO | Sale | −4,153 | $15.04 | $62K | 1,290,781 |
| 2021-06-08 | Forbes Alexandria President and CEO | Sale | −20,180 | $15.02 | $303K | 1,294,934 |
| 2021-06-08 | Naylor Stuart Chief Development Officer | Sale | −5,040 | $15.01 | $76K | 426,017 |
| 2021-06-07 | Forbes Alexandria President and CEO | Sale | −5,667 | $15.03 | $85K | 1,315,114 |
| 2021-06-07 | Naylor Stuart Chief Development Officer | Sale | −1,042 | $15.02 | $16K | 431,057 |
| 2021-04-30 | Naylor Stuart Chief Development Officer | Sale | −741 | $15.01 | $11K | 432,099 |
| 2021-04-30 | Naylor Stuart Chief Development Officer | Sale | +741 | $15.01 | $11K | 432,099 |
| 2021-04-29 | Naylor Stuart Chief Development Officer | Sale | −1,405 | $15.02 | $21K | 432,840 |
| 2021-04-29 | Naylor Stuart Chief Development Officer | Sale | −1,405 | $15.02 | $21K | 432,840 |
| 2021-04-28 | Naylor Stuart Chief Development Officer | Sale | −3,772 | $15.14 | $57K | 434,245 |
| 2021-04-28 | Naylor Stuart Chief Development Officer | Sale | −3,772 | $15.14 | $57K | 434,245 |
| 2021-03-15 | MARCUS JOEL S Director | Option exercise | +12,882 | $7.72 | $99K | 12,882 |
| 2021-03-15 | MARCUS JOEL S Director | Option exercise · Stock Option (right to buy) | −12,882 | 0 | ||
| 2021-03-05 | Forbes Alexandria President and CEO | Gift | −1,000 | 1,320,781 | ||
| 2021-02-17 | Forbes Alexandria President and CEO | Sale | −15,000 | $15.57 | $234K | 1,321,781 |
| 2021-02-16 | Forbes Alexandria President and CEO | Sale | −15,000 | $15.60 | $234K | 1,336,781 |
| 2021-01-14 | Wollin Robert J General Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2021-01-14 | Wollin Robert J General Counsel and Secretary | Grant or award · Restricted Share Units | +20,000 | 20,000 | ||
| 2021-01-14 | Zeldin Robert K Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-01-14 | Zeldin Robert K Chief Medical Officer | Grant or award · Restricted Share Units | +150,000 | 150,000 |
Page 18 of 21 · 411 trades